Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Prourokinase vs Tirofiban During Primary PCI for Acute Myocardial Infarction
NCT02131220Phase 4Completed
- Sponsor
- Fudan University
- Start
- Nov 2015
- Primary completion
- Aug 2017
- Modality
- Metabolic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human prourokinase in ST-segment elevation myocardial infarction (STEMI), sponsored by Fudan University. Started Nov 2015; status: completed.
02
Drugs
recombinant human prourokinase
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02131220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02131220.